home / stock / vcyt / vcyt articles

VCYT Articles, Veracyte Inc.

Stock Information
Company Name: Veracyte Inc.
Stock Symbol: VCYT
Market: NASDAQ
Website: veracyte.com
Menu
VCYT VCYT Quote VCYT Short VCYT News VCYT Articles VCYT Message Board
Get VCYT Alerts

News, Short Squeeze, Breakout and More Instantly...
3 Top-Ranked Efficient Stocks to Increase Your Portfolio Returns | Benzinga

A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price perform...
Buy 5 Medical Instruments Stocks to Enhance Your Portfolio | Benzinga

The Medical Instruments industry has been witnessing a gradual transition from remote healthcare and contactless services during the pandemic to it...

Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally | Benzinga

On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASDAQ:COIN) shares. Thi...

Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold | Benzinga

On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades. Among these, the firm’s decision to sell $9.3 milli...
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed | Benzinga

On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets ...

Cathie Wood's Ark Invest Buys Over $92M Worth Of ProShares Bitcoin ETF, Sells Coinbase, Block And Palantir Shares | Benzinga

On Wednesday, Cathie Wood-led Ark Invest made a significant move in the cryptocurrency space, purchasing over $92 million worth of ProShares Bitcoi...

Veracyte Stock Is Volatile After-Hours - Here's Why | Benzinga

Veracyte, Inc. (NASDAQ: VCYT) shares are volatile after-hours on Wednesday after the company announced that new data from a phase 3 trial validates...
Next 10